Mind Medicine (MindMed) (OTCMKTS:MMEDF) Shares Down 1.1%

Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDFGet Free Report)’s share price was down 1.1% during trading on Friday . The company traded as low as $9.26 and last traded at $9.40. Approximately 2,164,499 shares were traded during trading, a decline of 36% from the average daily volume of 3,376,665 shares. The stock had previously closed at $9.50.

Mind Medicine (MindMed) Stock Performance

The stock’s 50 day moving average price is $6.21 and its 200 day moving average price is $4.29.

About Mind Medicine (MindMed)

(Get Free Report)

Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.

Featured Stories

Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.